Mesenchymal Stem Cells as a Potent Cell Source for Bone Regeneration
Open Access
- 16 February 2012
- journal article
- review article
- Published by Hindawi Limited in Stem Cells International
- Vol. 2012, 1-9
Abstract
While small bone defects heal spontaneously, large bone defects need surgical intervention for bone transplantation. Autologous bone grafts are the best and safest strategy for bone repair. An alternative method is to use allogenic bone graft. Both methods have limitations, particularly when bone defects are of a critical size. In these cases, bone constructs created by tissue engineering technologies are of utmost importance. Cells are one main component in the manufacture of bone construct. A few cell types, including embryonic stem cells (ESCs), adult osteoblast, and adult stem cells, can be used for this purpose. Mesenchymal stem cells (MSCs), as adult stem cells, possess characteristics that make them good candidate for bone repair. This paper discusses different aspects of MSCs that render them an appropriate cell type for clinical use to promote bone regeneration.Keywords
This publication has 121 references indexed in Scilit:
- Optimizing the osteogenic potential of adult stem cells for skeletal regenerationJournal of Orthopaedic Research, 2011
- Culture media for the differentiation of mesenchymal stromal cellsActa Biomaterialia, 2011
- Mesenchymal stem cells suppress B-cell terminal differentiationExperimental Hematology, 2009
- The influence of three-dimensional nanofibrous scaffolds on the osteogenic differentiation of embryonic stem cellsBiomaterials, 2009
- Regenerative Effects of Transplanted Mesenchymal Stem Cells in Fracture HealingStem Cells, 2009
- Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative MedicineStem Cells, 2009
- Adipose-derived stem cells: Isolation, expansion and differentiation☆Methods, 2008
- Mesenchymal stromal cellsCurrent Opinion in Hematology, 2006
- The Evolving Concept of a Stem CellCell, 2001
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001